We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Vienna, Austria

ESTRO 2025

Session

Health economics & health services research
Digital Poster
Interdisciplinary
Effectiveness and Utility of the CECIL Patient Decision Aid for Cisplatin-Intolerant Cervical Cancer Patients (NCT05701735)
Warren Bacorro, Philippines
E25-11
Findings from a national survey on the use of simultaneous integrated boost techniques.
Raouia Ben Amor, Tunisia
E25-772
Global Quantitative Analysis of Clinical Trials in Radiation Oncology
Benoit ALLIGNET, France
E25-803
Assessing the earthquake vulnerability of radiotherapy centres in Türkiye
beril balci topuz, Turkey
E25-970
Development of an Electronic Framework to Guide the Procurement and Evaluation of Artificial Intelligence Based Software in Oncology
Susan Mercieca, Malta
E25-1007
Stage-Adjusted Forecasting of Radiotherapy Demand and Outcome Benefits Across Income Groups with Correlation to Cancer Plan Prioritisation
Mengqi Zhou, Australia
E25-1029
Time to Initial Consultation and Determinants of Delays in Radiation Oncology for Patients with Breast and Gynecologic Cancer
Ana Laura Rivero Pérez, Spain
E25-1154
Optimizing Workup Pathways To Decrease Radiotherapy Wait Times And Improve Patient Experience: Timely Access And Patient Support (TAPS) Model of Care
Kwamena Beecham, Canada
E25-1248
A novel framework for resource optimization demonstrated for brachytherapy: Integrating linear programming and discrete event simulation
Lente Christan, The Netherlands
E25-1385
Referral pathways in Radiation Oncology: A qualitative study of stakeholder experience across high income countries in Europe.
Claire Poole, Ireland
E25-1528
Assessing the use of respiratory motion management as a standard of care in India
Bhooshan Purushottam Zade, India
E25-39
Inequities in the Distribution of Radiotherapy Treatments Funded by the Public Health Insurance in Chile: Analysis 2018–2022
Gonzalo Ulloa, Chile
E25-1542
Security of Medical Data Exchange During International Collaboration Between Radiation Oncology Departments: Ensuring Privacy Rights
Mirosława Mocydlarz-Adamcewicz, Poland
E25-1593
Clinicians’ Perspectives on Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Breast Cancer: Findings from an International Survey
Sukhdeep Kaur Nagpal, United Kingdom
E25-1654
Cost-utility analysis of treatment for prostate cancer in a low-middle-income country in Latin America
Alejandro Gonzalez-Motta, Colombia
E25-1696
Cost comparison of silicone-based skin care with Mepitel® versus StrataXRT®: a prospective randomised controlled trial in post-mastectomy radiotherapy
Kirsty Stuart, Australia
E25-1814
Assessing Financial and Logistical Challenges of Proton Therapy: Insights from Patient-Reported Outcomes in Italy
Federico Mastroleo, Italy
E25-2088
Evaluating the impact of equipment downtime on patient care and economic efficiency in radiotherapy departments
Nadia Di Muzio, Italy
E25-2099
Improving availability & access to advanced radiotherapy techniques: A five-year case study of a networked international stereotactic program
Trent Aland, Australia
E25-2223
A Retrospective Study on the Assessment of Radiation Therapy Interruptions: Challenges and Solutions
AKSHATHA S, India
E25-2303
Bias in radiation therapy publications
Gerard Menezes, Ireland
E25-2418
Qualitative assessment to explore the added value and guide optimal use of the magnetic resonance linear accelerator in medical practice
Marike Ulehake, The Netherlands
E25-98
Management of processes in the division of Radiotherapy at ASST Papa Giovanni XXIII: application of the failure mode, effects and criticality analysis
Roberta MUNI, Italy
E25-2443
Enhancing Patient Awareness of Medical Physics Through Collaboration with Breast Cancer Associations
Sergio Lozares, Spain
E25-2581
Enabling Gantry-less radiotherapy through upright patient positioning: key insights from the ESTRO Physics Workshop 2024
Ye Zhang, Switzerland
E25-2684
Follow-up study on financial toxicity in cancer survivors having undergone proton therapy in Switzerland
Léonie Grawehr, Switzerland
E25-2710
The Influence of Socioeconomic Deprivation and Travel distance on Breast cancer-related outcomes in Saxony-Anhalt, Germany: Preliminary results.
Ahmed Bedir, Germany
E25-3268
The Impact of Educational Attainment on Access to Proton Radiation Therapy: A Scoping Review and Retrospective Patient Analysis
Fleur Arfman, The Netherlands
E25-3285
Capacity-limited triage in proton therapy: a ?NTCP prioritised waiting list to optimise capacity utilisation and ?NTCP gain
Eva Negenman, The Netherlands
E25-3297
Breaking barriers to early cancer detection: A multi-project study on emergency cancer diagnoses in the East of England.
Emily Scott, United Kingdom
E25-3372
Implementing an electronic platform for a proton therapy center: when research meets clinical practice from the first brick to future challenges
Daniela Alterio, Italy
E25-3439
Break-even analysis of improvements in adaptive RT: comparing incremental costs of advanced CBCT-imaging vs. incremental savings on planning-CTs
Diego Larrotta-Castillo, The Netherlands
E25-3533
Exploratory health economic analyses to support decisions within the innovation process in radiotherapy: MR-Linac as a case study
Marike Ulehake, The Netherlands
E25-99
Wearables: are they for all and are they the answer to continuous monitoring during and after radiotherapy?
Phil Fendall Amaro, United Kingdom
E25-3547
Estimation of benefits and risks of a preventive PET screening for early cancer detection
Kateryna Vilchynska, Ukraine
E25-3597
Cost-Effectiveness of Hypofractionation in Radiotherapy: Optimizing Resources and Access.
Miguel Ángel Espindola Sandoval, Mexico
E25-3709
Organisational Impact of 5 Fractions Radiotherapy in Adjuvant Breast Cancer Treatment in France
Gabriele Bielinyte, Lithuania
E25-3791
systematic literature review of particle therapy costing literature: a 20-years overview
Yaqeen Shanti, Belgium
E25-3857
Cost-effectiveness of locoregional hypofractionated RT in early breast cancer: evaluation alongside the HypoG-01 phase 3 Unicancer trial
Sofia Rivera, France
E25-3964
The Irish Research Radiation Oncology Group (IRROG). Setting up a national research radiation oncology group, the Irish experience to date.
Sinead Brennan, Ireland
E25-4066
When radiotherapy weighs on the wallet: A study of financial burden
Nejla Fourati, Tunisia
E25-4220
Advances in Radiotherapy Treatment in the Baltic States from 2016 to 2023 as seen through the lens of technology, delivery techniques and capacity
Erika Korobeinikova, Lithuania
E25-4294
Impacts of healthcare insurance sector on NSCLC diagnosis and survival: a population-based study in Brazil
Fernanda Malucelli Favorito, Brazil
E25-4518
Overcoming limitations during real life implementation of ePROM based symptom monitoring program for gynecologic radiotherapy.
Enar Recalde, Spain
E25-236
Accompain: a mobile application for pain monitoring in oncology patients
CAROLINA DE LA PINTA, Spain
E25-531
Integration of Artificial Intelligence in Radiation Oncology in Ireland: Challenges and Recommendations
Ciaran Malone, Ireland
E25-606
Hypofractionation to ultrahypofractionation for prostate cancer: A 5.5-Year Review of Time and Cost Efficiency
ILYA LVOVICH, Israel
E25-682